Metraipolis › archive › dc_f36dd0e13445
NFE2 and PF4 as biomarkers for BET inhibition-induced thrombocytopenia in preclinical and clinical studies — Europe PMC PMID:40937321
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40937321
- DOI
- 10.3389/fmed.2025.1592693
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T07:55:50.195Z
- SHA-256 of the archived text
732fff0c4232b6090f7baa9aceda879c5bca572c0884666f0895de150ea7e963- Stable URL of this page
https://metraipolis.com/documento/dc_f36dd0e13445
How to cite
NFE2 and PF4 as biomarkers for BET inhibition-induced thrombocytopenia in preclinical and clinical studies — Europe PMC PMID:40937321 — Europe PMC (en), https://europepmc.org/article/MED/40937321 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f36dd0e13445 (Metraipolis archive dc_f36dd0e13445, sha256 732fff0c4232b6090f7baa9aceda879c5bca572c0884666f0895de150ea7e963)
BibTeX
@misc{dcf36dd0e13445,
title = {NFE2 and PF4 as biomarkers for BET inhibition-induced thrombocytopenia in preclinical and clinical studies — Europe PMC PMID:40937321},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40937321},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f36dd0e13445; sha256 732fff0c4232b6090f7baa9aceda879c5bca572c0884666f0895de150ea7e963},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40937321. Agents can read the archived copy with the MCP tool read_document.